Opinion

Video

Emerging Agents in The Treatment of Gout

In this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.

1:10 Gout in the US

3:10 Gout and comorbidities

5:40 Diagnostic tools in gout

10:55 Treatment options for gout

13:10 IL-1 inhibitors in gout flares

14:00 Mechanisms to improve uric acid excretion

15:40 Options for treatment resistant gout

16:30 Uricases in treatment of gout

20:30 Pegloticase use in gout

22:50 Pegadricase in gout

23:30 Other therapeutic targets in gout

25:50 Challenges in monitoring patients with gout

29:50 Management of gout in patients with comorbid conditions

31:20 Final thoughts

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.